Clinical Trial

MICRO: a Registry Study in Patients With Microvascular Angina

Study acronym: MICRO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 31, 2022 (before its estimated October 10, 2024 completion). Its status may not reflect the trial's current state.
Summary
The evidence above demonstrates that microvascular dysfunction is an important determinant of patient prognosis, which however remains poorly classified. Given the high burden of disease and the severity of the functional impairment in these patients, the lack of a clear definition for this disease has a potentially large clinical importance. It is important to better describe the phenotype of these patients, identify the predictors of prognosis, and determine the impact of diagnosis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2020-10-27; most recent amendment 2022-03-29.
Trial Details
NCT Number NCT04612322
Lead Sponsor Johannes Gutenberg University Mainz
Conditions Microvascular Disease
Enrollment 1,000 participants
Start Date 2020-10-10
Primary Completion 2024-10-10 (estimated)
Study Completion 2029-10-10 (estimated)
Updated on ClinicalTrials.gov 2022-03-31